InnoCentive Integrates ChemAxon's Marvin JS
News Jun 05, 2015
ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, and InnoCentive, the global leader in crowdsourcing innovation solutions announce the integration of ChemAxon’s Marvin JS™, which enables convenient drawing of chemical structures and reactions/reaction mechanisms in InnoCentive’s innovation management software platform, InnoCentive@WorkTM.
ChemAxon has been involved in several collaborative, open innovation initiatives in the recent years. ChemAxon tools have been foundational part of Eli Lilly's OIDD (Open Innovation Drug Discovery) initiative aiming to provide a platform for idea-sharing among the network of top global research institutions. AstraZeneca enables research collaborations by providing a web-based open-innovation platform where chemical structures may be submitted. Molecule characterization is provided by ChemAxon. Similarly, ChemAxon provides core tools to support the European Lead Factory, a novel platform for innovative drug discovery, an IMI-supported public private partnership to enhance early drug discovery.
‘I am very excited about this partnership as crowdsourcing is becoming the next generation approach to problem solving’ - said Ferenc Csizmadia, CEO of ChemAxon. ‘We look forward to bringing more functionality as we extend our relationship with InnoCentive’
"Together with ChemAxon we have created the industry leading crowd sourcing solution for chemistry innovation. ChemAxon adds a critical innovators tool for new chemistry design for our Solvers to more easily compete for prizes in this field." – stated Craig Jones, Chairman and CEO of InnoCentive.
Getting to Know the Microbes that Drive Climate ChangeNews
A new understanding of the microbes and viruses in the thawing permafrost in Sweden may help scientists better predict the pace of climate change.READ MORE
How Many People Die From TB Every Year?News
Discrepancies between the estimates for global tuberculosis deaths is due to different methodologies and data sources used by each institution. The results highlight the need to improve the modeling approaches in these countries in order to understand the true burden of the disease and design adequate health policies.READ MORE
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.